Plasma Arachidonic Acid Influences Insulin-Stimulated Glucose Uptake in Healthy Adult Women

Annals of Nutrition and Metabolism - Tập 51 Số 5 - Trang 482-489 - 2007
José Luis Santos1, Carolina Aguirre1, Ricardo Uauy1,2, Erik O. Díaz3,1
1Laboratory of Energy Metabolism, Institute of Nutrition and Food Technology (INTA), and
2London School of Hygiene and Tropical Medicine, London, UK
3Department of Nutrition, Faculty of Medicine, University of Chile, Macul/Santiago, Chile

Tóm tắt

<i>Background:</i> Fatty acids can modulate lipid metabolism, this is related to insulin resistance (IR). This study evaluated the relationship of plasma fatty acid profile with IR, fuel oxidative metabolism and plasma lipid concentration in ‘healthy’ women. <i>Methods:</i> Sixteen ‘healthy’, sedentary and non-obese women were evaluated under fasting conditions for fuel oxidation, plasma fatty acid profile, free fatty acids, triglycerides, glucose and insulin concentrations. IR, fuel oxidation and plasma lipids were measured under insulin-stimulated conditions. Using the Spearman test the correlation between relevant variables was assessed. Stepwise multiple regression analysis was done to identify the main clinical/metabolic and fatty acid determinants of IR. <i>Results:</i> Plasma arachidonic acid content (%) determined IR, and in combination with insulin-stimulated plasma triglyceride concentration explained 45% of the IR variance. IR was inversely related to physical fitness (rs = –0.48, p = 0.01). The latter was inversely associated to plasma saturated fatty acid content (%) (rs = –0.48, p < 0.01), but directly associated to plasma docosahexaenoic acid content (%) (rs = 0.40, p = 0.04). <i>Conclusions:</i> Support for the hypothesis that specific fatty acids influence IR is provided. Plasma arachidonic acid was associated to IR, independent on clinical/metabolic study variables. Docosahexaenoic and saturated fatty acids could potentially affect insulin action through modulating mitochondrial oxidative function.

Từ khóa


Tài liệu tham khảo

10.1172%2FJCI5001

10.2337%2Fdiabetes.50.7.1612

10.1172%2FJCI118742

10.2337%2Fdiabetes.50.11.2579

10.1126%2Fscience.3303333

10.2337%2Fdiabetes.48.1.134

10.1016%2FS0026-0495%2896%2990058-X

10.1053%2Fmeta.2001.27195

10.1007%2FBF00400468

10.1016%2FS0952-3278%2802%2900265-X

10.1074%2Fjbc.R100062200

10.1146%2Fannurev.nutr.25.051804.101917

10.1210%2Fer.23.2.201

10.1007%2FBF00404344

10.1056%2FNEJM199301283280404

10.1038%2Fnature05485

10.1042%2FBST0330423

10.1172%2FJCI28003

10.2337%2Fdb06-S002

10.1042%2F0264-6021%3A3430191

10.1007%2Fs00125-002-0873-y

10.2337%2Fdiabetes.54.1.8

10.2337%2Fdb06-0783

10.1023%2FA%3A1005624707780

10.1007%2FBF02637075

10.1063%2F1.1380406

10.1007%2Fs00125-005-1686-6

10.2337%2Fdiabetes.52.9.2191

10.1210%2Fjc.2004-0943